The biggest update of 2024; ESC trials and guidelines

[@melesemknn]

Thank you so much!

[@CardioBuzz]

It’s my pleasure

[@wessamahmed6325]

Brilliant tutor and professor ❤

[@CardioBuzz]

🙏🏼🙏🏼🙏🏼

[@drshadyhamoda5849]

Amazing as always my dear prof

[@CardioBuzz]

Thanks a lot 😊

[@GhadaDodo-w1w]

Great,thank you sir very much. We need dedicated illustration to every new chapter nearly please 🙏 We have final master exam soon after 2 months. Please don't ignore 🙏

[@CardioBuzz]

I will try my best

[@stefanosloucaides1976]

RF-CL classifieds patients into very low,low and moderate(highest percentage 45). Then tell us for ex. high risk( >50% - 85%) indication for functional imaging. According to RF-CL how to categorise high and very high risk patients?

[@CardioBuzz]

Yes that’s a good question. We’ll answer that in one of the coming episodes

[@amirmansy5573]

Great as usual 👌

[@CardioBuzz]

Thanks again!

[@galinaandreeva1311]

Are you shure that new guidelines are really valuable for general practitioners?

[@CardioBuzz]

It really depends on your scope of practice. If you're treating patients with hypertension, angina, or atrial fibrillation, staying up to date with the latest evidence is definitely a good idea-especially since there are now patient-friendly versions of the guidelines available. But hey, if you have even better evidence, feel free to stick with what works for you!

[@HauGiang-j3d]

good video

[@CardioBuzz]

Thanks 😊

[@ahmadkhairy2134]

amazing

[@ghadasayed422]

Great